Atlas Trials

Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne

Clinical trial NCT07756957 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07756957
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acne
Start date
2026-10-30
Primary completion
2028-07-19
Enrollment
410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.